Catheter Precision, Inc. (VTAK)
NYSEAMERICAN: VTAK · Real-Time Price · USD
1.370
-0.040 (-2.84%)
At close: Mar 9, 2026, 4:00 PM EDT
1.370
0.00 (0.00%)
After-hours: Mar 9, 2026, 6:30 PM EDT

Company Description

Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States.

The company’s lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures.

It also offers LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures.

The company is based in Fort Mill, South Carolina.

Catheter Precision, Inc.
Catheter Precision logo
Country United States
Founded 2002
IPO Date Aug 30, 2018
Industry Medical Devices
Sector Healthcare
Employees 22
CEO David Jenkins

Contact Details

Address:
1670 Highway 160 West, Suite 205
Fort Mill, South Carolina 29708
United States
Phone 973 691 2000
Website catheterprecision.com

Stock Details

Ticker Symbol VTAK
Exchange NYSEAMERICAN
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001716621
CUSIP Number 74933X708
ISIN Number US74933X7084
Employer ID 38-3661826
SIC Code 3841

Key Executives

Name Position
David A. Jenkins Chief Executive Officer, Chief Commercial Officer and Executive Chairman
Margrit Thomassen CPA Controller
Philip J. Anderson Chief Financial Officer

Latest SEC Filings

Date Type Title
Mar 9, 2026 8-K Current Report
Feb 13, 2026 SCHEDULE 13G Filing
Feb 12, 2026 8-K Current Report
Feb 11, 2026 SCHEDULE 13G Filing
Feb 11, 2026 SCHEDULE 13G Filing
Feb 6, 2026 8-K Current Report
Jan 8, 2026 8-K Current Report
Nov 21, 2025 8-K Current Report
Nov 14, 2025 8-K Current Report
Nov 13, 2025 10-Q Quarterly Report